Literature DB >> 3656510

Florfenicol in non-lactating dairy cows: pharmacokinetics, binding to plasma proteins, and effects on phagocytosis by blood neutrophils.

K N Bretzlaff1, C A Neff-Davis, R S Ott, G D Koritz, B K Gustafsson, L E Davis.   

Abstract

Serial blood samples were collected and plasma concentrations of florfenicol (FLO) were measured following the administration of an intravenous bolus of 50 mg/kg FLO to five healthy non-lactating dairy cows. A triexponential equation provided the best fit of the data for four of the five cows. The mean value for beta corresponded to a half-life of 3.2 h. The mean apparent volume of distribution was 0.67 l/kg, and the mean body clearance was 0.15 l/kg/h. The extent of binding of FLO to bovine plasma proteins was determined in vitro at concentrations of 5 micrograms/ml and 50 micrograms/ml by equilibrium dialysis and ultrafiltration. The drug was 18% and 19% bound by equilibrium dialysis, and 23% and 19% bound by ultrafiltration, at 5 micrograms/ml and 50 micrograms/ml, respectively. Phagocytosis of 32phosphorus-labelled Staphylococcus aureus by bovine blood neutrophils was compared in vitro between neutrophils incubated in phosphate-buffered saline alone or in combination with 5, 125, or 1000 micrograms/ml chloramphenicol or FLO. There was no significant effect of chloramphenicol at any concentration. Florfenicol significantly inhibited phagocytosis at all concentrations, but the percentage inhibition was small. The clinical significance, if any, of this effect of FLO remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3656510     DOI: 10.1111/j.1365-2885.1987.tb00534.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  8 in total

1.  Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves.

Authors:  B A de Craene; P Deprez; E D'Haese; H J Nelis; W Van den Bossche; P De Leenheer
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

Review 2.  Current models in pharmacokinetics: applications in veterinary pharmacology.

Authors:  L D Kinabo; Q A McKellar
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

Review 3.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

4.  Tissue pharmacokinetics of florfenicol in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  Jian-Zhong Li; Ki-Fai Fung; Zhang-Liu Chen; Zhen-Ling Zeng; Jie Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Oct-Dec       Impact factor: 2.441

5.  Evaluation of florfenicol for the treatment of undifferentiated fever in feedlot calves in western Canada.

Authors:  C W Booker; G K Jim; P T Guichon; O C Schunicht; B E Thorlakson; P W Lockwood
Journal:  Can Vet J       Date:  1997-09       Impact factor: 1.008

6.  Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  Jianzhong Liu; Ki-Fai Fung; Zhangliu Chen; Zhenling Zeng; Jie Zhang
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

7.  An Interactive Generic Physiologically Based Pharmacokinetic (igPBPK) Modeling Platform to Predict Drug Withdrawal Intervals in Cattle and Swine: A Case Study on Flunixin, Florfenicol, and Penicillin G.

Authors:  Wei-Chun Chou; Lisa A Tell; Ronald E Baynes; Jennifer L Davis; Fiona P Maunsell; Jim E Riviere; Zhoumeng Lin
Journal:  Toxicol Sci       Date:  2022-07-28       Impact factor: 4.109

8.  Synovial and Systemic Pharmacokinetics of Florfenicol and PK/PD Integration against Streptococcus suis in Pigs.

Authors:  Zoltán Somogyi; Patrik Mag; Dóra Kovács; Ádám Kerek; Pál Szabó; László Makrai; Ákos Jerzsele
Journal:  Pharmaceutics       Date:  2022-01-03       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.